openPR Logo
Press release

ARTEC Discussed Key Successes and Future Plans for BOXER

03-20-2017 11:03 AM CET | Politics, Law & Society

Press release from: SMi Group

ARTEC Discussed Key Successes and Future Plans for BOXER

SMi Reports: A Q&A with Stefan Lischka, Managing Director of ARTEC ahead of his address at Future Armoured Vehicles Central & Eastern Europe 2017

ARTEC, a joint venture between Krauss-Maffei Wegmann (KMW) and Rheinmetall is the prime contractor for the BOXER development programme. ARTEC has confirmed their presence at SMi Group upcoming Future Armoured Vehicles Central & Eastern Europe Conference this May to showcase the latest advancement for the Boxer programme.

Established as Central & Eastern Europe's most focused armoured vehicles meeting, the conference will take place on 15th-16th May 2017 at the Andel’s Hotel in Prague, Czech Republic. With a large representation from the Czech Ministry of Defence, the 2017 show will bring together industry leaders from the region to give updates on modernisation plans and discuss how to enhance combat vehicle survivability as well as showcase progress on C4I and weapon systems technology.

Ahead of the conference, SMi Group have released an exclusive interview with Stefan Lischka to discuss key success and future plans for BOXER. Stefan has 25 years of experience working in the field and is currently the Managing Director of ARTEC since 2008.

As much interest has been placed on the recent decision of Lithuanian Armed Force to procure BOXER, we asked Stefan how this platform will add value to the strength of the Lithuanian Armed Forces and both domestically and on international operations.

“BOXER will provide the Lithuanian Armed Forces with a modern vehicle with very high levels of protection, survivability, firepower, mobility, payload and reliability with growth potential to remain in-service for the next 30 years.
It will significantly add to their home country protection capability and also enable them to operate with other allied forces in asymmetric NATO support operations.”

On future plans to upgrade the BOXER and creating a more versatile and modular defence vehicle, he commented:

“The modular concept and planned growth potential of BOXER make it an ideal platform for many combat solutions and future variants such as artillery, air defence, engineering, infantry fighting are being currently developed to suit enquires from potential customers.
Parallel to the physical development for these future variants the implantation of open standards architectures for electronics is being planned by participating in the NATO Generic Vehicle Architecture (NGVA) project.”
The full interview can be read in the event download centre at

Future Armoured Vehicles Central & Eastern Europe
15th & 16th May 2017
Andel’s Hotel, Prague, Czech Republic
Sponsored by: ARTEC, Burgess Consulting, General Dynamics, IBD Deisenroth, Lockheed Martin, Pearson Engineering, Rheinmetall CHEMPRO and SOUCY Group.

---- END ----

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

SMi Group
1 Westminster Bridge Rd, London SE1 7XW
Contact information:
For media enquiries contact Theresa Chung on Tel: +44 20 7827 6068 / Email:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ARTEC Discussed Key Successes and Future Plans for BOXER here

News-ID: 473357 • Views: 2106

More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK. The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines. Darren Green, Director of Computational Chemistry at GSK will be chairing at
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety. SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA. The 2022 Conference theme is
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022. Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022. This event will convene on February 9th – 10th 2022,

All 5 Releases